MXCT

NASDAQ 已收盘

MaxCyte, Inc.

1.11 USD
+0.02+3.74%
2026-08-03
市值
$118.91M
市盈率
EPS
-0.37
股息率
52 周区间
0.64 – 2.19
成交量
319.76K
Beta
1.66
目标价
4.11
52W 低 0.6452W 高 2.19
价格走势

公司简介

MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products consists of ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engi...